Found: 14
Select item for more details and to access through your institution.
Dose and cost comparison of erythropoietic agents in the inpatient hospital setting.
- Published in:
- American Journal of Health-System Pharmacy, 2007, v. 64, n. 18, p. 1943, doi. 10.2146/ajhp060585
- By:
- Publication type:
- Article
Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart review.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 9, p. 2089, doi. 10.1007/s00520-011-1318-2
- By:
- Publication type:
- Article
Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Comparative effectiveness, personalized medicine and innovation: the path forward.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Comparative Effectiveness, Personalized Medicine and Innovation.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 923, doi. 10.2165/11539030-000000000-0000010.2165/11537370-000000000-00000
- By:
- Publication type:
- Article
Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE): A Registry for Characterizing Anaemia Management and Outcomes in Oncology Patients.
- Published in:
- Clinical Drug Investigation, 2008, v. 28, n. 3, p. 159, doi. 10.2165/00044011-200828030-00003
- By:
- Publication type:
- Article
Dose Conversion and Cost Effectiveness of Erythropoietic Therapies in Chemotherapy-Related Anaemia: A Meta-Analysis.
- Published in:
- Clinical Drug Investigation, 2005, v. 25, n. 1, p. 33, doi. 10.2165/00044011-200525010-00004
- By:
- Publication type:
- Article
Impact of limiting erythropoiesis-stimulating agent use for chemotherapy-induced anemia on the United States blood supply margin.
- Published in:
- Transfusion, 2009, v. 49, n. 5, p. 895, doi. 10.1111/j.1537-2995.2008.02072.x
- By:
- Publication type:
- Article
Outcomes and charges of elderly patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2006, v. 81, n. 11, p. 850, doi. 10.1002/ajh.20683
- By:
- Publication type:
- Article
The Economic Impact of Epoetin Alfa Therapy on Delaying Time to Dialysis in Elderly Patients with Chronic Kidney Disease.
- Published in:
- Disease Management, 2007, v. 10, n. 1, p. 37, doi. 10.1089/dis.2006.626
- By:
- Publication type:
- Article
Anaemia and the Risk of Injurious Falls in a Community-Dwelling Elderly Population.
- Published in:
- Drugs & Aging, 2008, v. 25, n. 4, p. 325, doi. 10.2165/00002512-200825040-00005
- By:
- Publication type:
- Article
Dosing Patterns and Treatment Costs of Erythropoietic Agents in Elderly Patients with Pre- Dialysis Chronic Kidney Disease in Managed Care Organisations.
- Published in:
- Drugs & Aging, 2006, v. 23, n. 12, p. 969, doi. 10.2165/00002512-200623120-00004
- By:
- Publication type:
- Article
Effectiveness of Anti-Tumor Necrosis Factor Agents in the Treatment of Rheumatoid Arthritis: Observational Study.
- Published in:
- American Health & Drug Benefits, 2010, v. 3, n. 4, p. 266
- By:
- Publication type:
- Article
Health Plan Retention and Pharmacy Costs of Newly Diagnosed Patients with Chronic Kidney Disease in a Managed Care Population.
- Published in:
- American Health & Drug Benefits, 2009, v. 2, n. 7, p. 283
- By:
- Publication type:
- Article